CIK: 0001595851 · Show all filings
Period: Q1 2015 (← Previous) (Next →)
Filing Date: May 15, 2015
Total Value: $278M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SERIES TRUST | 100,000 | $22.55M | 8.1% | — | — | Put | 78464A870 |
| ZBH | ZIMMER HLDGS INC | 100,000 | $11.75M | 4.2% | $94.02 | +11.0% | COM | 98956P102 |
| — | ACTAVIS PLC | 35,000 | $10.42M | 3.7% | $262.80 | — | SHS | G0083B108 |
| — | ENDO HEALTH SOLUTIONS INC | 90,000 | $8.073M | 2.9% | $89.70 | — | NOTE 1.750% 4/1 | 29264FAB2 |
| CYH | COMMUNITY HEALTH SYS INC NEW | 150,000 | $7.842M | 2.8% | $41.41 | 0.0% | COM | 203668108 |
| — | NUVASIVE INC | 160,000 | $7.358M | 2.6% | $42.81 | — | COM | 670704105 |
| PBYI | PUMA BIOTECHNOLOGY INC | 30,000 | $7.083M | 2.5% | $214.23 | -0.2% | COM | 74587V107 |
| — | ZS PHARMA INC | 165,000 | $6.943M | 2.5% | $42.08 | — | COM | 98979G105 |
| — | ZELTIQ AESTHETICS INC | 225,000 | $6.937M | 2.5% | $25.00 | — | COM | 98933Q108 |
| — | CELGENE CORP | 60,000 | $6.917M | 2.5% | $115.28 | — | COM | 151020104 |
| — | PORTOLA PHARMACEUTICALS INC | 180,000 | $6.833M | 2.5% | $27.98 | — | COM | 737010108 |
| — | SAGE THERAPEUTICS INC | 120,000 | $6.028M | 2.2% | $50.23 | — | COM | 78667J108 |
| — | DYAX CORP | 350,000 | $5.864M | 2.1% | $14.25 | — | COM | 26746E103 |
| MMSI | MERIT MED SYS INC | 300,000 | $5.775M | 2.1% | $17.06 | +4.4% | COM | 589889104 |
| MRK | MERCK & CO INC NEW | 100,000 | $5.748M | 2.1% | $40.30 | 0.0% | COM | 58933Y105 |
| — | WRIGHT MED GROUP INC | 200,000 | $5.16M | 1.9% | $26.87 | — | COM | 98235T107 |
| BDX | BECTON DICKINSON & CO | 35,000 | $5.026M | 1.8% | $118.55 | 0.0% | COM | 075887109 |
| — | GENOCEA BIOSCIENCES INC | 420,000 | $4.981M | 1.8% | $11.86 | — | COM | 372427104 |
| — | NUVASIVE INC | 100,000 | $4.599M | 1.7% | $42.81 | — | Call | 670704105 |
| — | ALCOBRA LTD | 800,000 | $4.504M | 1.6% | $5.63 | — | SHS | M2239P109 |
| — | AVALANCHE BIOTECHNOLOGIES IN | 110,000 | $4.457M | 1.6% | $46.08 | — | COM | 05337G107 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 35,000 | $4.362M | 1.6% | $83.16 | +27.4% | COM | 09061G101 |
| — | SUNESIS PHARMACEUTICALS INC | 1,750,000 | $4.288M | 1.5% | $2.45 | — | COM NEW | 867328601 |
| — | CEPHEID | 75,000 | $4.268M | 1.5% | $54.14 | — | COM | 15670R107 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 40,000 | $4.177M | 1.5% | $71.51 | +41.7% | COM | 02043Q107 |
| A | AGILENT TECHNOLOGIES INC | 100,000 | $4.155M | 1.5% | — | — | Call | 00846U101 |
| — | REVANCE THERAPEUTICS INC | 200,000 | $4.146M | 1.5% | $20.73 | — | COM | 761330109 |
| — | GW PHARMACEUTICALS PLC | 45,000 | $4.101M | 1.5% | $91.13 | — | ADS | 36197T103 |
| ABBV | ABBVIE INC | 70,000 | $4.098M | 1.5% | $38.85 | 0.0% | COM | 00287Y109 |
| — | AVALANCHE BIOTECHNOLOGIES IN | 100,000 | $4.052M | 1.5% | $46.08 | — | Call | 05337G107 |
| ACAD | ACADIA PHARMACEUTICALS INC | 120,000 | $3.911M | 1.4% | $34.37 | 0.0% | COM | 004225108 |
| EXAS | EXACT SCIENCES CORP | 175,000 | $3.854M | 1.4% | $25.37 | 0.0% | COM | 30063P105 |
| FOLD | AMICUS THERAPEUTICS INC | 350,000 | $3.808M | 1.4% | $7.14 | +23.4% | COM | 03152W109 |
| — | ACHILLION PHARMACEUTICALS IN | 375,000 | $3.698M | 1.3% | $9.86 | — | COM | 00448Q201 |
| PTCT | PTC THERAPEUTICS INC | 60,000 | $3.651M | 1.3% | $36.53 | +67.0% | COM | 69366J200 |
| — | THERAPEUTICSMD INC | 600,000 | $3.63M | 1.3% | $5.07 | — | COM | 88338N107 |
| — | BLUEBIRD BIO INC | 30,000 | $3.623M | 1.3% | $35.89 | — | COM | 09609G100 |
| — | FLAMEL TECHNOLOGIES SA | 200,000 | $3.596M | 1.3% | $17.13 | — | SPONSORED ADR | 338488109 |
| INGN | INOGEN INC | 110,000 | $3.519M | 1.3% | $32.28 | 0.0% | COM | 45780L104 |
| — | VITAE PHARMACEUTICALS INC | 300,000 | $3.513M | 1.3% | $11.71 | — | COM | 92847N103 |
| — | DBV TECHNOLOGIES S A | 150,000 | $3.504M | 1.3% | $25.37 | — | SPONSORED ADR | 23306J101 |
| — | NANOSTRING TECHNOLOGIES INC | 335,000 | $3.414M | 1.2% | $12.42 | — | COM | 63009R109 |
| — | ENTELLUS MED INC | 150,000 | $3.285M | 1.2% | $21.90 | — | COM | 29363K105 |
| — | RADIUS HEALTH INC | 75,000 | $3.087M | 1.1% | $41.16 | — | COM NEW | 750469207 |
| — | DISCOVERY LABORATORIES INC N | 2,500,000 | $2.975M | 1.1% | $1.19 | — | COM NEW | 254668403 |
| — | PERNIX THERAPEUTICS HLDGS IN | 250,000 | $2.673M | 1.0% | $10.69 | — | COM | 71426V108 |
| — | IGNYTA INC | 250,000 | $2.488M | 0.9% | $9.95 | — | COM | 451731103 |
| — | LION BIOTECHNOLOGIES INC | 200,000 | $2.422M | 0.9% | $12.11 | — | COM | 53619R102 |
| — | TETRAPHASE PHARMACEUTICALS I | 65,000 | $2.382M | 0.9% | $36.65 | — | COM | 88165N105 |
| — | APPLIED GENETIC TECHNOL CORP | 116,750 | $2.334M | 0.8% | $19.99 | — | COM | 03820J100 |
| — | FIVE PRIME THERAPEUTICS INC | 100,000 | $2.285M | 0.8% | $22.85 | — | COM | 33830X104 |
| — | LOXO ONCOLOGY INC | 175,000 | $2.179M | 0.8% | $12.45 | — | COM | 548862101 |
| — | EPIZYME INC | 115,000 | $2.16M | 0.8% | $18.78 | — | COM | 29428V104 |
| — | BIODELIVERY SCIENCES INTL IN | 200,000 | $2.1M | 0.8% | $12.02 | — | Call | 09060J106 |
| — | CELLADON CORP | 100,000 | $1.894M | 0.7% | $19.17 | — | COM | 15117E107 |
| — | ADVAXIS INC | 125,000 | $1.805M | 0.6% | $8.01 | — | COM NEW | 007624208 |
| — | UNILIFE CORP NEW | 450,000 | $1.805M | 0.6% | $4.01 | — | COM | 90478E103 |
| PODD | INSULET CORP | 50,000 | $1.668M | 0.6% | $33.75 | 0.0% | COM | 45784P101 |
| — | ASSEMBLY BIOSCIENCES INC | 125,000 | $1.655M | 0.6% | $10.61 | — | COM | 045396108 |
| — | KINDRED BIOSCIENCES INC | 100,500 | $718K | 0.3% | $7.14 | — | COM | 494577109 |
| — | BIOLASE INC | 300,000 | $606K | 0.2% | $2.41 | — | COM | 090911108 |
| — | OCERA THERAPEUTICS INC | 125,000 | $589K | 0.2% | $10.04 | — | COM | 67552A108 |
| GBIM | GLOBEIMMUNE INC | 68,973 | $506K | 0.2% | $7.14 | +1.3% | COM | 37957B100 |
| — | XOMA CORP DEL | 72,000 | $262K | 0.1% | $3.64 | — | COM | 98419J107 |